Biotechnology · Healthcare
Board Member
2022-01-01–present
Board Member
Summit Therapeutics Inc. (SMMT)Board Member
Puma Biotechnology, Inc. (PBYI)Equibles does not estimate personal net worth.
Get an email with a short summary when Summit Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get SMMT alertsAlessandra Cesano is recorded as Board Member at Summit Therapeutics Inc. (SMMT) since January 1, 2022 and Board Member at Puma Biotechnology, Inc. (PBYI) since January 1, 2022. The newest filing on record that lists Alessandra Cesano as Board Member at Summit Therapeutics Inc. (SMMT) is dated April 17, 2026. The newest filing on record that lists Alessandra Cesano as Board Member at Puma Biotechnology, Inc. (PBYI) is dated April 28, 2026. Summit Therapeutics Inc. reported in an 8-K filed November 17, 2022 that Alessandra Cesano was appointed director, effective November 15, 2022. Puma Biotechnology, Inc. reported in an 8-K filed August 2, 2022 that Alessandra Cesano was appointed Board of Directors, effective July 29, 2022. Puma Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Summit Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Puma Biotechnology, Inc. includes Alan Auerbach (CEO and Board Member), Alan H. Auerbach (CEO and Board Member), Maximo Nougues (CFO) and 6 others.
“Effective on November 15, 2022, the board of directors (the "Board") of Summit Therapeutics Inc. (the "Company") unanimously approved (i) the election of Dr. Alessandra Cesano, MD, PhD as a director of the Company”
“On July 29, 2022, Alessandra Cesano, 62, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 29, 2022.”
2022-01-01–present
Last confirmed April 17, 2026
2022-01-01–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
Board Member
2022-01-01–present
Biotechnology · Healthcare
Board Member
2022-01-01–present